Braze, Inc. vs Microsoft Corporation — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
8.7
Very Bullish
Quality
Health
Growth
Valuation
Sentiment
BRZE
Consensus analyst target of $34.95 is 48% above current price.
⚠ currently unprofitable (-18% margin).
MSFT
Consensus analyst target of $561.93 is 36% above current price.
Analyst Consensus
BUY
Target $34.95 (+48.3%)
20 analysts
BUY
Target $561.93 (+35.6%)
52 analysts
Fundamentals
BRZE
MSFT
—
Trailing P/E
24.7×
24.0×
Forward P/E
21.5×
-17.8%
Profit Margin
39.3%
67.1%
Gross Margin
68.3%
-23.8%
ROE
34.0%
27.9%
Revenue Growth
18.3%
—
Earnings Growth
23.4%
0.89
Beta
1.11
—
Price / Book
—
$2.7B
Market Cap
$3.08T
$15 – $38
52-Week Range
$356 – $555
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →